Temporal Trends in Hepatitis C–Related Hospitalizations, United States, 2000–2019
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciad425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Megan G Hofmeister und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
Background
Hospitalization burden related to hepatitis C virus (HCV) infection is substantial. We sought to describe temporal trends in hospitalization rates before and after release of direct-acting antiviral (DAA) agents.
Methods
We analyzed 2000–2019 data from adults aged ≥18 years in the National Inpatient Sample. Hospitalizations were HCV-related if (1) hepatitis C was the primary diagnosis, or (2) hepatitis C was any secondary diagnosis with a liver-related primary diagnosis. We analyzed characteristics of HCV-related hospitalizations nationally and examined trends in age-adjusted hospitalization rates.
Results
During 2000–2019, there were an estimated 1 286 397 HCV-related hospitalizations in the United States. The annual age-adjusted hospitalization rate was lowest in 2019 (18.7/100 000 population) and highest in 2012 (29.6/100 000 population). Most hospitalizations occurred among persons aged 45–64 years (71.8%), males (67.1%), White non-Hispanic persons (60.5%), and Medicaid/Medicare recipients (64.0%). The national age-adjusted hospitalization rate increased during 2000–2003 (annual percentage change [APC], 9.4%; P < .001) and 2003–2013 (APC, 1.8%; P < .001) before decreasing during 2013–2019 (APC, −7.6%; P < .001). Comparing 2000 to 2019, the largest increases in hospitalization rates occurred among persons aged 55–64 years (132.9%), Medicaid recipients (41.6%), and Black non-Hispanic persons (22.3%).
Conclusions
Although multiple factors likely contributed, overall HCV-related hospitalization rates declined steadily after 2013, coinciding with the release of DAAs. However, the declines were not observed equally among age, race/ethnicity, or insurance categories. Expanded access to DAA treatment is needed, particularly among Medicaid and Medicare recipients, to reduce disparities and morbidity and eliminate hepatitis C as a public health threat.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia.
ORCID-Profile: Megan G Hofmeister
Förderung
- Intramural CDC HHS
Zitieren
APA
Hofmeister, M. G., Zhong, Y., Moorman, A. C., Samuel, C. R., Teshale, E. H., & Spradling, P. R. (2023). Temporal Trends in Hepatitis C–Related Hospitalizations, United States, 2000–2019. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad425
Vancouver
Hofmeister MG, Zhong Y, Moorman AC, Samuel CR, Teshale EH, Spradling PR. Temporal Trends in Hepatitis C–Related Hospitalizations, United States, 2000–2019. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad425
BibTeX
@article{Hofmeister2023,
author = {Hofmeister, Megan G and Zhong, Yuna and Moorman, Anne C and Samuel, Christina R and Teshale, Eyasu H and Spradling, Philip R},
title = {Temporal Trends in Hepatitis C–Related Hospitalizations, United States, 2000–2019},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciad425}
}
EUVIMED